Temporal pattern of C1q deposition after transient focal cerebral ischemia

被引:33
作者
Mack, WJ
Sughrue, ME
Ducruet, AF
Mocco, J
Sosunov, SA
Hassid, BG
Silverberg, JZ
Ten, VS
Pinsky, DJ
Connolly, ES
机构
[1] Columbia Univ, Dept Neurol Surg, Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10032 USA
[3] Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA
关键词
cerebral ischemia; mouse; complement; C1q; neuroprotection; reperfusion injury;
D O I
10.1002/jnr.20775
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have focused on elucidating the contribution of individual complement proteins to post-ischemic cellular injury. As the timing of complement activation and deposition after cerebral ischemia is not well understood, our study investigates the temporal pattern of C1q accumulation after experimental murine stroke. Brains were harvested from mice subjected to transient focal cerebral ischemia at 3, 6, 12, and 24 hr post reperfusion. Western blotting and light microscopy were employed to determine the temporal course of C1q protein accumulation and correlate this sequence with infarct evolution observed with TTC staining. Confocal microscopy was utilized to further characterize the cellular localization and characteristics of C1q deposition. Western Blot analysis showed that C1q protein begins to accumulate in the ischemic hemisphere between 3 and 6 hr post-ischemia. Light microscopy confirmed these findings, showing concurrent C1q protein staining of neurons. Confocal microscopy demonstrated colocalization of C1q protein with neuronal cell bodies as well as necrotic cellular debris. These experiments demonstrate the accumulation of C1q protein on neurons during the period of greatest infarct evolution. This data provides information regarding the optimal time window during which a potentially neuroprotective anti-C1q strategy is most likely to achieve therapeutic success. (C) 2006 Wiley-Liss, Inc.
引用
收藏
页码:883 / 889
页数:7
相关论文
共 26 条
[1]   Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats [J].
Belayev, L ;
Busto, R ;
Zhao, WZ ;
Ginsberg, MD .
BRAIN RESEARCH, 1996, 739 (1-2) :88-96
[2]   Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [J].
Botto, M ;
Dell'Agnola, C ;
Bygrave, AE ;
Thompson, EM ;
Cook, HT ;
Petry, F ;
Loos, M ;
Pandolfi, PP ;
Walport, MJ .
NATURE GENETICS, 1998, 19 (01) :56-59
[3]   Complement activation in heart diseases: Role of oxidants [J].
Chakraborti, T ;
Mandal, A ;
Mandal, M ;
Das, S ;
Chakraborti, S .
CELLULAR SIGNALLING, 2000, 12 (9-10) :607-617
[4]  
Collard CD, 1997, CIRCULATION, V96, P326
[5]   Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia [J].
Connolly, ES ;
Winfree, CJ ;
Stern, DM ;
Solomon, RA ;
Pinsky, DJ .
NEUROSURGERY, 1996, 38 (03) :523-531
[6]   The role of the complement cascade in ischemia/reperfusion injury: Implications for neuroprotection [J].
D'Ambrosio, AL ;
Pinsky, DJ ;
Connolly, ES .
MOLECULAR MEDICINE, 2001, 7 (06) :367-382
[7]   Tactics for vascular protection after acute ischemic stroke [J].
Fagan, SC ;
Hess, DC ;
Machado, LS ;
Hohnadel, EJ ;
Pollock, DM ;
Ergul, A .
PHARMACOTHERAPY, 2005, 25 (03) :387-395
[8]  
GASQUE P, 1992, J IMMUNOL, V149, P1381
[9]  
GASQUE P, 1993, J BIOL CHEM, V268, P25068
[10]   Complement components of the innate immune system in health and disease in the CNS [J].
Gasque, P ;
Dean, YD ;
McGreal, EP ;
VanBeek, J ;
Morgan, BP .
IMMUNOPHARMACOLOGY, 2000, 49 (1-2) :171-186